Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection Can Be the Best Therapeutic Option in Severely Immunocompromised Patients Depending on a Case-by-Case Assessment of the Benefit-to-Risk Ratio.

Benech, N.; Cassir, N.; Galperine, T.; Alric, L.; Scanzi, J.; Sokol, H.

doi:10.1053/j.gastro.2024.04.022

Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection Can Be the Best Therapeutic Option in Severely Immunocompromised Patients Depending on a Case-by-Case Assessment of the Benefit-to-Risk Ratio.

Détails

Demande d'une copie

ID Serval

serval:BIB_22B215888B2C

Type

Article: article d'un périodique ou d'un magazine.

Sous-type

Etude de cas (case report): rapporte une observation et la commente brièvement.

Collection

Publications

Institution

UNIL/CHUV

Titre

Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection Can Be the Best Therapeutic Option in Severely Immunocompromised Patients Depending on a Case-by-Case Assessment of the Benefit-to-Risk Ratio.

Périodique

Gastroenterology

Auteur⸱e⸱s

Benech N., Cassir N., Galperine T., Alric L., Scanzi J., Sokol H.

Collaborateur⸱rice⸱s

French Fecal Transplant Group

Contributeur⸱rice⸱s

Benech N., Cassir N., Alric L., Melchior C., Mosca A., Joly A.C., Kapel N., Barbut F., Galperine T., Pigneur B., Davido B., Schneider S., Briot T., Wasiak M., Nebad B., Batista R., Mosca A., Bleibtreu A., Scanzi J., Sokol H., Sintes R., Corriger A., Flet L., Perlemuter G., Ahloulay M., Yaye H.S., De Rougemont A., Olivier E., Burucoa C., Gobert J.G., Landman C., Vignal L., Joly F., Ravinet A., Bellanger A., Sabate J.M., Humbert C., Wisnewsky J.A., Charpentier C., Moreno-Sabater A., Takoudju C., Poirier P., Tanne F., De Lastours V., Stampfli C.

ISSN

1528-0012 (Electronic)

ISSN-L

0016-5085

Statut éditorial

Publié

Date de publication

08/2024

Peer-reviewed

Oui

Volume

167

Numéro

3

Pages

627-628

Langue

anglais

Notes

Publication types: Journal Article ; Case Reports ; Letter
Publication Status: ppublish

Mots-clé

Humans, Fecal Microbiota Transplantation/adverse effects, Immunocompromised Host, Clostridium Infections/therapy, Clostridium Infections/diagnosis, Clostridium Infections/microbiology, Clostridium Infections/immunology, Clostridioides difficile, Risk Assessment, Recurrence, Male, Female, Treatment Outcome, Middle Aged, Aged

OAI-PMH

oai:serval.unil.ch:BIB_22B215888B2C

DOI

10.1053/j.gastro.2024.04.022

Pubmed

38679396

Web of science

001276926100001

Open Access

Oui

Création de la notice

03/05/2024 15:12